Scopus BioPharma Inc. Common Stock
SCPS
SCPS was delisted on the 16th of December, 2022.
28 hedge funds and large institutions have $4.89M invested in Scopus BioPharma Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.
1,200% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 2
666% more capital invested
Capital invested by funds: $639K → $4.89M (+$4.25M)
600% more funds holding
Funds holding: 4 → 28 (+24)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.13M |
| 2 |
Millennium Management
New York
|
+$963K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$546K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$498K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$492K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$242K |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$223K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$12.3K |
| 4 |
First Manhattan
New York
|
-$1.05K |
SCPS Hedge Fund Activity: Q1 2021 in Review
28 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Scopus BioPharma Inc. Common Stock (SCPS) for Q1 2021, worth a combined $4.89M — up 666% from $639K a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new SCPS positions and 2 closed out — a net gain of 24 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $1.13M. The largest seller was Virtu Financial, exiting entirely with an estimated $242K sold.
- 28 institutional investors held Scopus BioPharma Inc. Common Stock (SCPS) as of Q1 2021, up from 4 in Q4 2020.
- Funds reported $4.89M of Scopus BioPharma Inc. Common Stock stock for Q1 2021, up 666% quarter-over-quarter.
- 26 funds opened new Scopus BioPharma Inc. Common Stock positions in Q1 2021 and 2 closed out, a net change of +24 holders.
- The largest Scopus BioPharma Inc. Common Stock buyer in Q1 2021 was BlackRock, an estimated $1.13M added.
- The largest Scopus BioPharma Inc. Common Stock seller in Q1 2021 was Virtu Financial, an estimated $242K sold.
Based on aggregated 13F filings for Q1 2021.